CTOs on the Move

Apollo Informations Services Inc

www.aisi-med.com

 
Apollo Informations Services Inc is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.aisi-med.com
  • 4350 Fowler St Ste 15
    Fort Myers, FL USA 33901
  • Phone: 888.632.0545

Executives

Name Title Contact Details

Similar Companies

HealthChannels

With 15,000 employees across 50 states, HealthChannels provides everything your practice needs to revolutionize how healthcare is delivered. What started as the nation`s most-used medical scribe company has grown into a group of three distinct, highly-specialized companies; ScribeAmerica, CareThrough, and QueueLogix. Together, these “channels” enable providers to improve clinical outcomes by providing highly-skilled clerical support for EMR documentation, patient engagement, medical coding and so much more.

CDRG.ca (Canadian Disaster Restoration Group)

CDRG.ca (Canadian Disaster Restoration Group) is a Gloucester, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Angel Attic Community Inc

Angel Attic Community Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Angel Attic Community Inc is based in Middleton, WI. You can find more information on Angel Attic Community Inc at www.atticangel.org

Cardium Therapeutics, Inc.

Cardium Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Cardium Therapeutics, Inc., please visit www.cardiumthx.com

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.